Company intelligence / Profile preview

Rosalie

Nashville, Tennessee, United States

Ownership: Private
Development stage: Other

Overview

Rosalie is a medical aesthetics company focused on developing innovative treatments for skin health and aging. Founded in 2023 by Dustin Sjuts, the former President of Revance Therapeutics, the company leverages a leadership team with deep expertise in the aesthetics and dermatology sectors. Rosalie aims to advance the science of beauty through the development of next-generation therapeutic products, including potential neuromodulators and dermal fillers. Based in Nashville, Tennessee, the company is currently in the early stages of building its proprietary pipeline. Rosalie's mission is to disrupt the traditional aesthetics market by providing high-quality, science-backed solutions for cosmetic and medical dermatology needs.

Therapeutic areas: Dermatology
Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on Rosalie.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rosalie.

Explore the full profile